Cannabis Law Report

APRIL 21, 2022

MDMA is a promising psychedelic compound, currently placed by the Drug Enforcement Administration (DEA) in Schedule I of the Controlled Substances Act, that has been produced for legal research in small batches by certified laboratories. The safety and efficacy of MDMA-assisted therapy is currently under investigation. MEDIA CONTACT .

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

JANUARY 11, 2019

Accordingly, the Drug Enforcement Administration (DEA) no longer has any claim to interfere with the interstate commerce of hemp products, so as long as the THC level is at or below 0.3%. While the DEA is now officially out of the hemp regulation business, the U.S. The FDA’s position on CBD is unsettled and unsupported by law.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

SpeedWeed

SEPTEMBER 7, 2021

There was no testing information, no information about the manufacturer, no product safety assurance whatsoever. . Drug Enforcement Administration (DEA) recently moved to counter that argument. . DEA’s July 2021 update. And that could have a major impact on product safety. . Not a whole lot. But the U.S.

Vaping 52

Vaping Oil DEA Packaging 52

PrestoDoctor

JULY 16, 2019

NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy. The nature of the federal ruling places pressure on the DEA to move quickly; faster than if the CCA were to attempt to reduce the scheduling through other channels such as congress.

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy. The nature of the federal ruling places pressure on the DEA to move quickly; faster than if the CCA were to attempt to reduce the scheduling through other channels such as congress.

Policy 40

Policy DEA Access Media 40

SpeedWeed

MARCH 7, 2021

In the latest episode of the Cannacurio Podcast from Cannabiz Media, my co-host, Amanda Guerrero, and I discuss license updates coming to the Cannabiz Media License Database, including Oregon cannabis licenses, Louisiana CBD licenses, and Pennsylvania, Ohio, Montana and South Carolina hemp licenses. That’s gotten huge.

Extraction 52

Extraction Data Hemp Research and Development 52

Cannabis Law Report

MAY 1, 2019

There are a multitude of media outlets publishing ads for cannabis businesses, and we are not aware of any prosecutions of such outlets. Attorney has claimed that newspapers, radio stations, and other media outlets that published advertisements for state-legal medical cannabis dispensaries are violating federal law. ” 25.

Legalization 45

Legalization Business Law Cannabis 45

Cannabis Law Report

NOVEMBER 2, 2021

Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? At present, with almost no regulation over the industry, there is a definite risk of what chemist and hemp safety expert Dr. Matthew Curran describes to Refinery29 as “kitchen chemistry.” Table of Contents. Executive Summary.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

FEBRUARY 28, 2022

Show More According to the Drug Enforcement Administration (DEA), Schedule I drugs have “no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.” 11 × 11. In 2017, the FDA designated MDMA a breakthrough therapy for PTSD. Feduccia et al.,

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

OCTOBER 25, 2019

Four years ago, the establishment media and politicians told us legalizing marijuana was “too radical.” Ensure a just reentry for people leaving incarceration as detailed in Bernie’s Justice and Safety for All plan. Regulate the safety of marijuana products by granting the federal government regulatory authority. Vox [link].

Programs 55

Programs Safety Access Business 55

Cannabis Law Report

SEPTEMBER 19, 2019

Here are three of the most pressing matters that might give Congress absolutely no choice but to surrender to marijuana legalization in the interest of public health and safety. . . “ It is already causing a slew of problems in states across the nation. Reason #1: Police confused on how to distinguish the difference between?

Vaping 55

Vaping Hemp Education Patients 55

Veriheal

FEBRUARY 1, 2021

The filing is backed by MAPS (Multidisciplinary Association for Psychedelic Studies) and calls on the DEA to answer a four-year-old filing requesting approval of his application to become a federally registered marijuana cultivator. According to media sources, there are about 30 others waiting to hear from the feds too. Why the delay?

DEA 76

DEA Therapy Cultivation Media 76

Cannabis Law Report

SEPTEMBER 29, 2021

The national media took notice of some of the highlights: Rep. Many producers expressed concerns that the DEA’s interim final rule would criminalize the processing of hemp extracts. The bill would also get rid of the USDA’s requirement that only DEA laboratories can test hemp products. Discussion centered around H.R.

Hemp 52

Hemp Banking Legislation Policy 52